Myeloid Therapeutics
Clinical trials sponsored by Myeloid Therapeutics, explained in plain language.
-
New drug MT-304 tested in patients with advanced HER2 cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called MT-304, alone or with another drug (nivolumab), in adults with advanced HER2-expressing solid tumors. The main goals are to check safety and find the best dose. About 60 participants will receive the treatment every two to four weeks…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New drug takes on advanced liver cancer in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called MT-303 in about 70 adults with advanced liver cancer that has spread or cannot be removed. The drug targets a protein (GPC3) found on these cancer cells. The main goals are to check safety, find the best dose, and see if it works whe…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated May 19, 2026 12:01 UTC